國家衛生研究院 NHRI:Item 3990099045/10028

NHRI > Institute of Molecular and Genomic Medicine > Li-Rung Huang > Conference Papers/Meeting Abstract > Item 3990099045/10028

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10028

Title:	Metabolic reprogramming of myeloid cells during tumor progression
Authors:	Huang, LR;Jian, SL;Jhou, YJ;Chen, WW
Contributors:	Institute of Molecular and Genomic Medicine
Abstract:	Myeloid-derived suppressor cells (MDSCs) are heterogeneous populations of immature myeloid cells, which expand and differentiate in responses to growth factors, cytokines and chemokines derived from cancer cells and then are released from bone marrow to peripheral tissues including tumor sites. MDSCs play important roles not only in T-cell suppression but also in angiogenesis, lymphangiogenesis and metastasis during tumor progression. The influence of tumor cells on the activation and proliferation of myeloid cells has been extensively studied. However little is known about the metabolic status of MDSCs during tumor progression. We therefore try to elucidate the metabolic changes during differentiation of myeloid cells into MDSCs. We have found that myeloid cells up-regulated their glycolytic pathway and immunosuppressive features when encountering cancer cells in vitro. Results from DNA microarray and real-time PCR also revealed that monocytic and granulocytic MDSCs from primary tumor sites of 4T1 tumor-bearing mice promoted their glycolysis in comparison to their healthy counterparts, monocytes and neutrophils, from bone marrow of healthy mice. We further proved that glycolytic pathway contributed to the survival and immunosuppression of MDSCs in vitro and in vivo using a hexokinase inhibitor, 2-DG, to block glycolysis. We are currently examining the association of metabolites from glycolysis and differentiation of myeloid cells during tumor progression and expect to identify specific metabolite responsible for driving differentiation of MDSCs.
Date:	2016-08
Relation:	European Journal of Immunology. 2016 Aug;46(Suppl. 1):213-214.
Link to:	http://dx.doi.org/10.1002/eji.201670200
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0014-2980&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000383610400432
Appears in Collections:	[Li-Rung Huang] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000383610400432.pdf		167Kb	Adobe PDF	539	View/Open

Loading...